SCHEMBL16279902

SCHEMBL16279902

Cc1cc(C)n(-c2cccc(Oc3ccc4c5ccccc5n(-c5cc(-c6ccccc6)ccn5)c4c3[Pt])c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 2/20 0.39
RXFP1 Q9HBX9 2/20 0.39
SCN9A Q15858 2/20 0.35
ALDH1A1 P00352 1/20 0.35
DGAT2 Q96PD7 1/20 0.32
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
MEN1 O00255 1/20 0.31
APEX1 P27695 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TP53 P04637 1/20 0.31
TSHR P16473 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16280258 0.91 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280566 0.91 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280426 0.90 SMN1; SMN2 (0.41) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280381 0.89 SMN1; SMN2 (0.38) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280090 0.88 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1ALDH1A1RAB9A
SCHEMBL16280449 0.87 POLB (0.36) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280372 0.86 SMN1; SMN2 (0.42) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280039 0.85 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16280203 0.85 SMN1; SMN2 (0.41) SMN1; SMN2POLBRXFP1SCN9AALDH1A1
SCHEMBL16279899 0.85 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1SCN9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10211414-B2 Phosphorescent tetradentate metal complexes having modified emission spectra ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-02-19 US disclosed
US-20170331056-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-11-16 US disclosed
US-9673409-B2 Phosphorescent tetradentate metal complexes having modified emission spectra ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2017-06-06 US disclosed
WO-2015027060-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-02-26 WO disclosed
US-20140364605-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2014-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170331056-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA AP2S1, PICALM, TRPC3 SMN1; SMN2 2678/4885POLB 2889/4885RXFP1 4793/4885
US-10211414-B2 Phosphorescent tetradentate metal complexes having modified emission spectra AP2S1, PICALM, TRPC3 SMN1; SMN2 2678/4885POLB 2889/4885RXFP1 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.